Information  X 
Enter a valid email address

Alpha Real Tst Ltd (ARTL)

  Print      Mail a friend

Tuesday 25 September, 2018

Alpha Real Tst Ltd

Admission to Trading

RNS Number : 8952B
Alpha Real Trust Limited
25 September 2018
 

25 September 2018

LEI: 213800BMY95CP6CYXK69 

 

 

ALPHA REAL TRUST LIMITED ("ALPHA REAL TRUST" OR THE "COMPANY")

Admission to Trading

 

The Company announces that on 25 September 2018, 79,647 class A shares of no par value were converted into ordinary shares of the Company and were subsequently admitted to trading on the Specialist Fund Segment under its ordinary share blocklisting facility.

 

These ordinary shares rank pari passu with the existing ordinary shares.

 

The total voting rights in the Company remains at 68,486,906 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Alpha Real Trust under the FCA's Disclosure and Transparency Rules.

 

For further information please contact:

 

Alpha Real Trust Limited

David Jeffreys, Chairman, Alpha Real Trust                              +44 (0) 1481 231 100

Brad Bauman, Joint Fund Manager, Alpha Real Trust               +44 (0) 20 7391 4700

Panmure Gordon, Broker to the Company

Richard Gray / Andrew Potts                                                   +44 (0) 20 7886 2500

 

About the Company

The Company is a closed-ended investment company incorporated in Guernsey that targets investment and development opportunities in real estate, including real estate operating companies, securities, services and other related businesses that offer high total returns.

Further information on the Company can be found on the Company's website: www.alpharealtrustlimited.com.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCPGUQWBUPRGWA

a d v e r t i s e m e n t